Severe acute respiratory syndrome-associated coronavirus IVDs - ARTG 409956

Access comprehensive regulatory information for Severe acute respiratory syndrome-associated coronavirus IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 409956 and sponsored by Wellwisse Pharmaceuticals Pty Ltd, manufactured by Hangzhou Testsea Biotechnology Co Ltd in China. The device registration started on June 02, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.